Research Article Open Access

The Use of a Combination Vaccine in International Travelers Visiting Countries with High Endemic Rates of Hepatitis A and/or Hepatitis B

Bradley A. Connor1, Susan Anderson2 and Robert Steffen3
  • 1 The Weill Medical College of Cornell University, United States
  • 2 Stanford University School of Medicine, United States
  • 3 University of Zurich Travel Health Center, Switzerland

Abstract

Hepatitis A and B represent a significant threat to international travelers. Both diseases are preventable through vaccination, though fewer than half of at-risk visitors in endemic regions are protected. Current vaccination recommendations should be revised to ensure adequate immunity for all international travelers against hepatitis A and B, as both diseases pose comparable danger. Since exposure to the viruses cannot be predicted, vaccination should be offered to all individuals visiting destinations with intermediate or high endemicities of hepatitis A and/or B, regardless of length of stay and standard of accommodation. Risk groups and endemicity of hepatitis A and B overlap, therefore, a combination vaccine against both forms is beneficial.

American Journal of Infectious Diseases
Volume 4 No. 2, 2008, 104-108

DOI: https://doi.org/10.3844/ajidsp.2008.104.108

Submitted On: 6 September 2007 Published On: 30 June 2008

How to Cite: Connor, B. A., Anderson, S. & Steffen, R. (2008). The Use of a Combination Vaccine in International Travelers Visiting Countries with High Endemic Rates of Hepatitis A and/or Hepatitis B. American Journal of Infectious Diseases, 4(2), 104-108. https://doi.org/10.3844/ajidsp.2008.104.108

  • 2,034 Views
  • 1,592 Downloads
  • 0 Citations

Download

Keywords

  • Twinrix
  • travel medicine
  • hepatitis vaccination